Correlation Between Beijing Wantai and China Reform

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Beijing Wantai and China Reform at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beijing Wantai and China Reform into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Beijing Wantai Biological and China Reform Health, you can compare the effects of market volatilities on Beijing Wantai and China Reform and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beijing Wantai with a short position of China Reform. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beijing Wantai and China Reform.

Diversification Opportunities for Beijing Wantai and China Reform

0.69
  Correlation Coefficient

Poor diversification

The 3 months correlation between Beijing and China is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Beijing Wantai Biological and China Reform Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China Reform Health and Beijing Wantai is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beijing Wantai Biological are associated (or correlated) with China Reform. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China Reform Health has no effect on the direction of Beijing Wantai i.e., Beijing Wantai and China Reform go up and down completely randomly.

Pair Corralation between Beijing Wantai and China Reform

Assuming the 90 days trading horizon Beijing Wantai Biological is expected to generate 0.95 times more return on investment than China Reform. However, Beijing Wantai Biological is 1.05 times less risky than China Reform. It trades about -0.17 of its potential returns per unit of risk. China Reform Health is currently generating about -0.37 per unit of risk. If you would invest  7,395  in Beijing Wantai Biological on October 24, 2024 and sell it today you would lose (555.00) from holding Beijing Wantai Biological or give up 7.51% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Beijing Wantai Biological  vs.  China Reform Health

 Performance 
       Timeline  
Beijing Wantai Biological 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Beijing Wantai Biological has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
China Reform Health 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days China Reform Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Beijing Wantai and China Reform Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Beijing Wantai and China Reform

The main advantage of trading using opposite Beijing Wantai and China Reform positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beijing Wantai position performs unexpectedly, China Reform can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Reform will offset losses from the drop in China Reform's long position.
The idea behind Beijing Wantai Biological and China Reform Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing